Click on the subcategory below to find drug monographs for that particular area.
PCV 13, a 13-valent pneumococcal conjugate vaccine, showed a favorable safety profile and immunogenicity when administered concomitantly with DTaP, a report at at IDWeek 2012 demonstrated.
Results from a Phase 2 study reported on at IDWeek 2012 showed that the 5555 formulation of tetravalent dengue vaccine elicits the highest serpositivity rates and balanced response against all four serotypes with a satisfactory safety profile.
Alzheimer's disease (AD) symptoms stabilize among patients treated with intravenous immunoglobulin (IVIG) for 36 months.
Quickly and accurately perform clinical calculations.
